AGP Executive Report
Last update: 8 hours agoMedical Cannabis: Boots has launched the UK’s first high-street pharmacy service to privately prescribe cannabis for some patients with chronic pain, anxiety or insomnia after conventional treatments have failed. Prescriptions will be reviewed by clinicians, with patient outcomes studied alongside the University of Nottingham. Hemp Rules: US restrictions on hemp-derived THC products are nearing a December start, leaving businesses bracing for major losses; industry groups are pushing for regulation instead of a broad crackdown. Product Safety: California labs say a costly cannabis-testing machine failed to reliably detect several pesticides. The public impact is unknown, and labs have asked state officials to investigate. Pennsylvania Legalization: Despite Democrats winning control of the legislature, incoming Senate leader Jay Costa says adult-use legalization is not a top priority, putting reform plans in doubt.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.